EUVIMED · CrossrefJournal
Blood
ISSN 0006-4971 · American Society of Hematology
Frequent topics
HOXAT-cell acute lymphoblastic leukemiaTLX1TLX3WT1 mutationschromosomal deletionpediatric leukemiaprognostic valuerelapsetumor suppressor
Latest articles
Rewriting resistance: NRAS resets AML cell state
Not everything that looks like a gametocyte is malaria
When it comes to therapeutics, new is good, but what we really need are breakthrough drugs and products
Not noninferior: what OPTI-AML really tells us
Solving for X in R-CHOP+X: is epcoritamab the answer?
Factor V gains a direct anticoagulant role
The PAX to FLT3 targeting
Histidine-rich glycoprotein is the new “antithrombin V”
Beyond cyclosporine alone in moderate aplastic anemia
Eltrombopag for moderate aplastic anemia
Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway
Cytokines to modulate CAR T cells
Microbiota-derived short-chain fatty acids control cGVHD development by regulating antibody production
Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody
Regenerative Stress Contributes to Higher Clonal Hematopoiesis with Myelodysplastic Features in Sickle Cell Disease Mice
CENTRAL NERVOUS SYSTEM GRAFT VERSUS HOST DISEASE PATHOPHYSIOLOGY: MECHANISTIC PATHWAYS AND THERAPEUTIC TARGETS
Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial
Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS
Functional restoration of immune defects in STAT1 gain-of-function disease after stem cell gene editing
CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma
Clinical and genomic convergence of high-risk CCUS and lower-risk myelodysplastic syndromes/neoplasms
Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004
Sapablursen for erythrocytosis control in patients with polycythemia vera
Pathological effects of NETs: seed and soil hypothesis for inflammation spread by primed neutrophils
CAR-T Targeting of Mutant Calreticulin Selectively Eradicates Myeloproliferative Neoplasm-Sustaining Stem Cells
Targeting TMPRSS6 in β-thalassemia: of mice and men
Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study
Paravertebral extramedullary chronic myelomonocytic leukemia mimicking myeloid sarcoma
Et tu, CD70? When friend turns foe for follicular lymphoma
Volumes
2026 · 9532025 · 9,1932024 · 8,8242023 · 8,2682022 · 7,0522021 · 5,8972020 · 5,0902019 · 6,7762018 · 6,8782017 · 1,5302016 · 7,1882015 · 6,8932014 · 7,3302013 · 6,9972012 · 6,9272011 · 7,3502010 · 6,9352009 · 6,9722008 · 7,1562007 · 6,8042006 · 7,0672005 · 7,1102004 · 6,8452003 · 1,6812002 · 1,5022001 · 1,2742000 · 2,0851999 · 1,7411998 · 2,1601997 · 1,6761996 · 1,6011995 · 1,3441994 · 2,0691993 · 1,9891992 · 1,9231991 · 1,7741990 · 1,5291989 · 1,4921988 · 1,2541987 · 1,192
EUVIMED